A “Weak Spot” In HIV Boosts AIDS Vaccine Efforts
Researchers from the National Institutes of Health have discovered a new “weak spot”, called fusion peptide, that helps the virus fuse with a cell. The fusion peptide can be the vulnerable site on HIV for vaccines to target. Since VRC34.01 is the only antibody that works, scientists now, have to find similar antibodies in patients without VRC34.01.
read more @ Futurism
